Rivaroxaban significantly inhibits the stimulatory effects of bone-modulating hormones:In vitrostudy of primary female osteoblasts-Reference-Cited by-同舟云学术

Rivaroxaban significantly inhibits the stimulatory effects of bone-modulating hormones:In vitrostudy of primary female osteoblasts

Published:2016-09-23 Issue:2 Volume:58 Page:215-220
ISSN:0300-8207
Container-title:Connective Tissue Research
language:en
Short-container-title:Connective Tissue Research

Author:

Somjen Dalia¹,Sharfman Zachary T.²,Katzburg Sara¹,Sharon Orli¹,Maman Eran²,Salai Moshe²,Stern Naftali¹,Dolkart Oleg²

Affiliation:

1. Institute of Endocrinology, Metabolism and Hypertension, Tel-Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

2. Division of Orthopedic Surgery, Tel-Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

Publisher

Informa UK Limited

Subject

Cell Biology,Molecular Biology,Orthopedics and Sports Medicine,Biochemistry,Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03008207.2016.1220942

Reference18 articles.

1. Practical Management of Rivaroxaban for the Treatment of Venous Thromboembolism

2. Effects of heparin on osteoclast activity

3. Osteoblast Growth Inhibition by Unfractionated Heparin and by Low Molecular Weight Heparins: An in-vitro Investigation

4. Effects of Low Molecular Weight Heparin and Unfragmented Heparin on Induction of Osteoporosis in Rats

5. A Histomorphometric Comparison of the Effects of Heparin and Low-Molecular-Weight Heparin on Cancellous Bone in Rats

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of Potential Ewing Sarcoma Drugs from FDA-Approved Pharmaceuticals through Computational Drug Repositioning, Pharmacogenomics, Molecular Docking, and MD Simulation Studies;ACS Omega;2022-06-01

2. FVIII at the crossroad of coagulation, bone and immune biology: Emerging evidence of biological activities beyond hemostasis;Drug Discovery Today;2022-01

3. Osteoporosis and antithrombotic therapy;Russian Journal of Cardiology;2021-06-11

4. Anticoagulants and Osteoporosis;International Journal of Molecular Sciences;2019-10-24